So You Want To Make A Biosimilar: Top Considerations Before BLA Submission
LexBlog IP
SEPTEMBER 7, 2023
Developing and successfully commercializing a biosimilar is a complex and expensive process. Topics that will be covered include the 271(e) Safe Harbor, peremptory challenges, labelling and timing considerations, and competitive intelligence. Click here to register for the webinar.
Let's personalize your content